The Potential Role and Effective Components of Sanyeqing as the Potential Therapeutic Candidates for IBD and CRC.

36 , 37 The latest global cancer epidemiological data show that the morbidity and mortality of colorectal cancer rank fourth and second among malignant tumors, respectively, and the prevalence of this cancer shows an increasing trend year by year. 38 There were over 1.9 million new cases and resulted in approximately 935,000 fatalities globally. 39 Individuals diagnosed with IBDs, including ulcerative colitis and Crohn’s disease, exhibit a notably heightened risk for the development of colorectal cancer. 40 , 41 According to va

also in 63,971 other papers